Clinical Trials Directory

Trials / Unknown

UnknownNCT01783119

Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
National Institute of Medical Sciences and Nutrition, Salvador Zubiran · Academic / Other
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Not accepted

Summary

The Ulcerative Colitis (UC) belongs to the group of diseases called Inflammatory Bowel Disease (IBD) which is characterized by a chronic ulceration of the colon. The conventional treatment can have adverse effects and does not guarantee effectiveness in some patients requiring aggressive therapy using adjuvant therapy Aloe vera has been shown to have a beneficial effect in different disease, and have an anti-inflammatory effect in UC patients. Objective: Measuring the effect of the consumption of 200 ml of aloe vera gel daily for a period of three months, in the degree of inflammation in patients with mild UC based on Mayo scale and quantification of IL-6 in the colonic mucosa.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAloe Barbadensis Miller
DIETARY_SUPPLEMENTplacebo water

Timeline

Start date
2012-08-01
Primary completion
2013-12-01
Completion
2014-12-01
First posted
2013-02-04
Last updated
2013-02-04

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT01783119. Inclusion in this directory is not an endorsement.

Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis (NCT01783119) · Clinical Trials Directory